Orientador: Licio Augusto Velloso / Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas / Made available in DSpace on 2018-08-08T07:52:20Z (GMT). No. of bitstreams: 1 Oliveira_FernandoGanzarollide_D.pdf: 2241345 bytes, checksum: a0f9e9616ce36521fc221d40146a8e97 (MD5) Previous issue date: 2005 / Resumo: Angiotensina II (AngII) desempenha um papel importante na gênese da hipertrofia miocárdica. Grande parte do estímulo hipertrófico determinado pela AngII depende da ativação de sinalização intracelular envolvendo membros das famílias de transdutores de sinais mitogen-activated-protein kinase (MAPK) e Janus Kinase (JAK)/ signal transducer and activator of transcription (STAT). Agentes farmacológicos doadores de óxido nítrico (NO) estão sendo objeto de intensa pesquisa, atualmente, pelo seu potencial terapêutico em condições clínicas envolvidas na hipertrofia miocárdica. No presente trabalho, avaliamos a propriedade do S-nitroso-acetilcisteína (SNAC) de modular a transdução de sinal da AngII mediada por membros da família das MAPK e JAK/STAT em coração e cardiomiócitos isolados de ratos. SNAC foi capaz de reverter significativamente a ativação promovida pela AngII na via de sinalização JAK2/STAT1 e 3 em coração e cardiomiócitos. Além disso, SNAC reverteu a ativação por AngII em cJun-N-terminal Kinase (JNK)1/2/3. Entretanto, SNAC acentuou o efeito da AngII em Extracellular Regulated Kinase (ERK) 1 e 2. Finalmente, nem AngII nem SNAC exerceram qualquer efeito sobre p38MAPK. Como resultado, houve menor expressão dos immediate early genes c-jun e c-fos, bem como menor ativação por fosforilação da proteína c-Jun. Em resumo, o pré-tratamento de ratos e cardiomiócitos isolados com um potente doador de NO afeta a transdução do sinal da AngII resultando na modulação via-específica da expressão de genes precocemente induzidos. Tais resultados oferecem evidências para o efeito direto de um doador de NO sobre a transdução de sinal da AngII e proporcionam bases moleculares para as propriedades anti-hipertróficas desta classe de drogas / Abstract: Angiotensin II (AngII) plays an important role in the genesis of cardiac hypertrophy. Much of the growth stimulus delivered by AngII depends on the activation of intracellular signaling through members of the mitogen-activated-protein kinase (MAPK) and Janus kinase (JAK)/ signal transducer and activator of transcription (STAT) family of signal transducers. Pharmacological agents that act as donors of nitric oxide (NO) are currently under intensive investigation for their beneficial role in clinical conditions that produce cardiac hypertrophy. Here, we evaluated the property of S-nitroso-N-acetyl cysteine (SNAC) to modulate AngII signal transduction through members of the MAPK family and through JAK2/STAT-1 and 3 in heart and isolated cardiomyocytes of rats. SNAC significantly reversed AngII activation of the JAK2/STAT-1 and -3 signaling in heart and cardiomyocytes. In addition SNAC revered AngII activation of JNK1/2/3. However, SNAC enhanced the effect of AngII on ERK. Finally neither SNAC nor AngII exerted an effect on p-38. As a consequence, there was an abrogation in the enhanced expression of the immediately early genes c-jun and c-fos, as well the phosphorilation of c-Jun. In summary, the treatment of living rats and isolated cardiomyocytes with a potent NO donor affects AngII signal transduction on a pathway specific manner resulting on the modulation of early inducible gene expression. These results provide evidence for a direct effect of a NO donor upon AngII signal transduction, and grant a molecular basis for the anti-hypertrophic properties of this class of drugs / Doutorado / Clinica Medica / Doutor em Clínica Médica

Orientadores: Carmen Verissima Ferreira, Hiroshi Aoyama / Tese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-08T07:42:49Z (GMT). No. of bitstreams: 1 Souza_AnaCarolinaSantosde_D.pdf: 3901394 bytes, checksum: ef9ac69de23f7f2b15590ee29a931c8f (MD5) Previous issue date: 2007 / Resumo: Produtos naturais têm originado muitos dos compostos biologicamente ativos usados clinicamente, destacando-se como importantes fontes de novos agentes terapêuticos utilizados no tratamento das mais variadas patologias incluindo câncer, HIV/AIDS, Alzheimer e malária. O desenvolvimento de novos fármacos a partir de produtos naturais, especialmente os derivados de plantas, tem desempenhado importante papel na prevenção e tratamento do câncer sendo que, de todos os antitumorais disponíveis entre 1940 e 2002, aproximadamente 40% eram caracterizados como produtos naturais ou derivados destes, com outros 8% sendo considerados agentes mimetizantes de produtos naturais. No presente trabalho, fisetin (flavonóide de origem vegetal) e a vitamina riboflavina foram avaliados como potenciais agentes antitumorais. Para este propósito, as linhagens de células leucêmicas HL60 e de câncer prostático PC3 foram tratadas com riboflavina irradiada ou fisetin por 24 horas e seus efeitos sobre vias de transdução de sinais responsáveis pela sobrevivência e morte celular foram avaliados. Os resultados obtidos demonstram que riboflavina e fisetin apresentam expressiva atividade antiproliferativa, induzindo a morte das células tumorais em concentrações na ordem de µM. A investigação do mecanismo molecular da ação citotóxica da riboflavina demonstrou que o tratamento de HL60 e PC3 com a vitamina irradiada induz morte celular através da via extrínseca de indução de apoptose, mediada pela ativação do sistema Fas/FasL e aumento na síntese de ceramida. Como conseqüência da ativação do receptor de morte Fas, uma seqüência ordenada de eventos leva à modulação de cascatas de sinalização através da alteração da atividade/expressão de moléculas-chave associadas a proliferação, sobrevivência, migração e morte celular. Assim como a riboflavina, fisetin também mostra-se eficiente indutor de morte por apoptose em células HL60, modulando cascatas de proteínas quinases e fosfatases e levando a alterações na expressão de NF?B, atividade de MAPKs, níveis de fosfoproteínas e, também, à inibição de enzimas envolvidas na manutenção do estado redox. Os resultados obtidos neste trabalho contribuem para um maior conhecimento sobre a atividade/função biológica de algumas moléculas envolvidas na sobrevivência e morte de células leucêmicas e prostáticas, sugerindo potenciais alvos para o desenvolvimento de estratégias terapêuticas mais eficazes no combate a doenças neoplásicas. Além disso, os resultados obtidos demonstram que a riboflavina irradiada e fisetin são potentes indutores de apoptose e promissores agentes antitumorais, capazes de modular importantes vias de sinalização intracelular através de ação específica sobre moléculas-chaves relacionadas a proliferação, resistência e invasividade de células tumorais / Abstract: Natural products have been providing numerous clinically used medicines and remain as essential components in the search for new drugs against various pharmacological targets including cancer, HIV/AIDS, Alzheimer¿s, malaria, and pain. Drug discovery from natural products, especially from medicinal plants, has played an important role in the chemoprevention and treatment of cancer and, off all available anticancer drugs between 1940 and 2002, about 40% were natural products per se or natural product-derived, with another 8% considered natural product mimics. In the present work, the plant flavonoid fisetin and the vitamin riboflavin are evaluated as potential anticancer agents. For this purpose, the leukemic cell line HL60 and the human prostate cancer cell PC3 were treated for 24h with irradiated riboflavin or fisetin and their effects on signal transduction pathways related to the cell survival and proliferation were evaluated. The results obtained demonstrated that riboflavin and fisetin have strong anti-proliferative activity, inducing tumoral cell death at µM concentrations. The investigation of the molecular death mechanism triggered by riboflavin demonstrated that the treatment of HL60 and PC3 with the irradiated vitamin induces apoptotic cell death through induction of the extrinsic pathway mediated by the activation of Fas/FasL system via a ceramide-dependent pathway. As a consequence of the activation of the death receptor Fas, an orderly sequence of signaling events leads to the modulation of signaling cascades through alterations in the activity/expression of key targets molecules related to proliferation, survival, migration and cell death. As well as riboflavin, fisetin also showed strong apoptotic activity, inducing HL60 cell death through modulation of protein kinase and phosphatase signaling cascades, leading to alterations in the NF?B expression, MAPKs activities, phosphoprotein levels and also inhibition of enzymes involved in the redox status maintenance. The results obtained in this work bring out information about the biologic activity of some molecules involved in the survival and death of leukemic and prostate cancer cells, indicating among then potential targets for the development of rational therapeutic strategies. Moreover, the data obtained demonstrated that irradiated riboflavin and fisetin have potential proapoptotic activity, pointing out these bioactive compounds as promising antitumoral agents, since they can affect important molecular targets related to proliferation, resistance and invasibility of cancer cells / Doutorado / Bioquimica / Doutor em Biologia Funcional e Molecular

Orientador: Carmen Verissima Ferreira / Tese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-14T15:16:22Z (GMT). No. of bitstreams: 1 ChavesNeto_AntonioHernandes_D.pdf: 8240508 bytes, checksum: 293949f75ca619cdc0fa61d29d1703ba (MD5) Previous issue date: 2009 / Resumo: Riboflavina (Rb - Vitamina B2) é o precursor das flavocoenzimas essenciais flavina mononucleotídeo (FMN) e flavina adenina dinucleotídeo (FAD). Estas coenzimas participam de processos enzimáticos dependentes das reações de transferências de elétrons, que ocorrem nas vias de produção de energia, biossíntese, desintoxicação e sequestro de elétrons. O aumento dietético da riboflavina e piridoxina foi associado com maiores densidades minerais em mulheres e homens idosos. Fotoderivados da riboflavina demonstraram efeitos citotóxicos em células cancerosas de próstata e leucemias, entretanto, o efeito direto da Rb e seus fotoderivados em osteoblastos não foram examinados. Neste trabalho os efeitos biológicos da Rb e riboflavina irradiada (IRb) foram investigados na linhagem de pré-osteoblastos MC3T3-E1, um modelo bem aceito de osteogênese in vitro caracterizado pela indução de genes específicos associados com o fenótipo osteoblástico quando tratados com ácido ascórbico e ß-glicerofosfato. A viabilidade celular foi avaliada através da redução do MTT, da incorporação do corante vermelho neutro e do conteúdo de ácidos nucléicos. Marcadores de diferenciação osteoblástica foram analisados através do RT-PCR semi-quantitativo (osteopontina e osteocalcina) e através de análises colorimétricas de atividade da fosfatase alcalina (FAL) e síntese de colágeno pela coloração de picrosirius. As atividades das metaloproteinases (MMP) -9 e -2 foram avaliadas pela zimografia de gelatina. Microarranjos de peptídeos com subtratos específicos para quinases e imunoblotting foram usados para identificar os efeitos na sinalização celular. As atividades de enzimas antioxidantes (superóxido dismutase, catalase, glutationa peroxidase e glutationa S-transferase) foram determinadas em lisados celulares usando métodos espectrofotométricos. As atividades das caspases-8, -9 e -3 foram analisadas através de métodos colorimétricos. Na primeira análise Rb e IRb causaram a parada do ciclo celular na fase G0/G1 e também a inibição da quinase AKT, um mediador da proliferação. Flavinas causaram a diferenciação de pré-osteoblastos, evidenciada pelo aumento da expressão de osteocalcina, osteopontina e BMP-2. Atividades mais elevadas de MMP-9 e MMP-2 também foram observadas. A capacidade das flavinas em engatilhar a diferenciação de osteoblastos foi reforçada pelo aumento da conexina 43, diminuição da caveolina-1 e repressão da sinalização Notch. Na segunda análise, nós encontramos que as interações entre Rb, em sua forma irradiada e não-irradiada, e indutores osteogênicos (ácido ascórbico e ß-glicerofosfato) afetaram significativamente a proliferação de osteoblastos, a atividade de FAL, biossíntese de colágeno, expressão de osteocalcina e osteopontina, a atividade das MMP-2 e MMP-9 e a expressão de fatores osteoclastogênicos (RANKL e osteoprotegerina). Nós também encontramos que os efeitos das flavinas em osteoblastos nesta segunda etapa foram independentes das suas propriedades antioxidantes. A atividade biológica da combinação de indutores osteogênicas com Rb e seus fotoprodutos foi associada com a ativação de diferentes vias de sinalização (AKT, FAK, CaMKII), caspases -8, -9 e -3 e aumento da expressão e/ou estabilização de fatores de transcrição osteoblásticos (Runx2 e ß-catenin). Este estudo nos trouxe fortes evidências que altas concentrações de Rb e IRb geraram um microambiente osteogênico através da modulação de diferentes vias de sinalização, além de promover um efeitos aditivo durante a diferenciação das células pré-osteoblasticas MC3T3 induzida por ácido ascórbico e ß- glicerofosfato. Em resumo, este estudo aponta para uma potencial aplicação da Rb e seus fotoprodutos no desenvolvimento do fenótipo osteoblástico e, consequentemente, uma alternativa terapêutica coadjuvante para osteoporose. / Abstract: Riboflavin (Rb-Vitamin B2) is the precursor of essential flavocoenzymes, flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). These coenzymes participate in numerous enzymatic processes dependent on electron transfer reactions that occur in energyproducing, biosynthetic, and detoxifying and electron-scavenging pathways. Increase dietary riboflavin and pyridoxine intake has been associated with higher bone mineral density in elderly men and women. Photoderivatives of riboflavin have been shown strong activity in haematological malignancy and prostate cancer cells, however, the direct effect of Rb and its photoderivatives on osteoblast has not been examined. In this work, the biologic effects of Rb and irradiated riboflavin (IRb) were investigated in the MC3T3-E1 pre-osteoblastic cell line, a well-accepted model of osteogenesis in vitro characterized for the induction of specific genes associated with the osteoblastic phenotype when treated with ascorbic acid and ß-glycerophosphate. Cell viability was assessed by MTT reduction, neutral red uptake and nucleic acids content. Osteoblastic differentiation markers were analyzed by semiquantitative RT-PCR (osteopontin and osteocalcin), alkaline phosphatase (ALP) activity measured colorimetrically and collagen synthesis by Sirius red staining. Metalloproteinases (MMP) -9 and -2 activities were assayed by gelatin zymography. Peptide microarray of substrate specificity to kinases and immunoblotting were used to identify the effects on signal transduction pathways. Antioxidant enzyme activities (superoxide dismutase, catalase, glutathione peroxidase and glutathione Stransferase) were determined in cellular lysate using spectrophotometric methods. Caspase-8, -9 and -3 activation were measured by a colorimetric assay. In the first analysis Rb and IRb caused cell cycle arrest at G0/G1 phase and accordingly inhibited AKT kinase, a proliferation mediator. Flavins caused differentiation of preosteoblast cells as evidenced by increase of osteocalcin, osteopontin and BMP2 expressions. In addition, higher MMP-9 and -2 activities were observed. Importantly, the capacity of flavins to trigger osteoblasts differentiation was also reinforced by upregulation of connexin 43, down regulation of caveolin-1 and negative modulation of Notch cascade. In the second analysis, we found that the interaction between Rb and IRb and osteogenic inductors (ascorbic acid and ß-glycerophosphate) significantly affected the osteoblast proliferation, alkaline phosphatase activity, collagen biosynthesis, osteopontin and osteocalcin mRNA expression, MMP-2 and MMP-9 activities and the expression of osteoclastogenesis factors (RANKL and OPG). We also showed that the effects of flavins in osteoblasts cells were independent on flavins antioxidant property. The biological activity of the combination of osteogenic medium with riboflavin and its photoderivatives was associated with the activation of different signaling pathways (AKT, FAK, CaMKII), caspases -8, -9 and -3, and up-regulation and/or stabilization of osteoblastic transcription factors (Runx2 and ß-catenin). This study brought out strong evidences that high concentration of Rb and IRb generates an osteogenic microenvironment through modulating different mediators of signaling pathways, besides of the additive effect of riboflavin and its photoproducts during the ascorbate and ß-glycerophosphateinduced osteoblast differentiation of MC3T3-E1 cells. In summary, this study pointed out the potential application of Rb and its photoproducts in osteoblasts phenotype development and, consequently, it is possible use as an alternative therapeutic adjuvant of osteoporosis. / Doutorado / Bioquimica / Doutor em Biologia Funcional e Molecular

O parasita da malária Plasmodium falciparum percebe o ambiente em que se encontra, elaborando respostas celulares adequadas, que envolvem secreção de proteínas, crescimento e diferenciação celular. Fatores relacionados com a geração de segundos-mensageiros e proteínas efetoras da sinalização celular estão descritos na literatura. Porém, a função de receptores responsáveis pela percepção de estímulos extracelulares no parasita é um tema pouco explorado. A identificação in silico de receptores de sete domínios transmembrânicos putativos no genoma de P. falciparum possibilitou a exploração da função dos mesmos. A tese caracteriza funcionalmente dois receptores, PFSR10 e PFSR25. A expressão proteica dos receptores foi demonstrada em fases eritrocíticas de P. falciparum. Os receptores possuem candidatos a parceiros moleculares que executam diversas funções celulares, entre elas invasão do eritrócito, endocitose e exocitose. Os receptores foram transfectados em células de mamíferos e, através de ensaios de dinâmica de cálcio de high-throughput, sugere-se que PFSR10 codifique um receptor que participa na percepção de ATP extracelular e que PFSR25 codifique um sensor de KCl. O trabalho também sugere que KCl modula cálcio citosólico em P. falciparum e que parasitas nocaute para PFSR25 são incapazes de modular cálcio citosólico em resposta a KCl. / The malaria parasite P. falciparum perceives its milieu and elaborates adequate intracellular responses, that involve protein secretion, growth and cell differentiation. Factors related to second messengers generation and effectors of cell signaling are described in the literature. However, the function of receptors responsible for stimulus perception remains elusive. The in silico identification of putative seven transmembrane receptors in the Plasmodium falciparum genome allowed the exploration of their function. In the thesis, two putative receptors were characterized, PFSR10 and PFSR25. The proteic expression of the receptors was demonstrated in erythrocytic stages of P. falciparum. The receptors have putative interaction partners that participate in cellular functions such as invasion, exocytosis and endocytosis.The receptors were transfected in mammalian cells and, through high-throughput calcium dynamics assays, it is suggested that PFSR10 codes for a receptor that participates in extracellular ATP perception and that PFSR25 codes for a KCl sensor. It is also suggested that KCl modulates cytosolic calcium in response to KCl and that knockout parasites for PFSR25 are incapable of modulating cytosolic calcium in response to KCl.

Orientadores: Patrícia Maria Bergamo Favaro, Sara Teresinha Olalla Saad / Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas / Made available in DSpace on 2018-08-26T08:01:05Z (GMT). No. of bitstreams: 1 Pereira_JoaoKleberNovais_M.pdf: 3579832 bytes, checksum: 2f21cc28ac6161522a1ab6a958a04389 (MD5) Previous issue date: 2014 / Resumo: As neoplasias linfoides constituem um grupo heterogêneo de doenças originadas por alterações genéticas das células progenitoras hematopoéticas de origem linfoide, levando à proliferação clonal desordenada de células B ou T, e ao desenvolvimento de leucemias linfoides e linfomas. É notória a participação de diferentes vias de sinalização envolvidas tanto no desenvolvimento como na manutenção das neoplasias hematológicas. A ativação constitutiva da via de sinalização PI3K/AKT/mTOR é bem descrita na leucemia linfoide aguda de células T (LLA-T) e recentemente identificou-se, em modelos animais, que a atividade da PI3K coopera com o desenvolvimento do linfoma de Burkitt (LB). Deste modo, o papel da via PI3K/AKT/mTOR no crescimento e sobrevivência celular, duas características importantes da leucemogênese, transformou-a em um potencial alvo farmacológico. Seguindo essa perspectiva, o presente trabalho procurou avaliar o potencial terapêutico de NVP-BKM120, um pan-inibidor de PI3K de classe I, em linhagens celulares de LLA-T (Jurkat e MOLT-4) e LB (Daudi e NAMALWA). NVP-BKM120 foi capaz de diminuir a viabilidade celular e capacidade clonogênica dessas células. Foi observada uma parada na fase G2/M do ciclo celular, com subsequente diminuição de Ciclina B1 e aumento da apoptose pelas vias intrínseca e extrínseca, nas linhagens Jurkat, MOLT-4 e NAMALWA. Também foi observada diminuição da fosforilação da AKT e dos alvos downstream ao mTORC1, P70S6K e 4EBP1, e aumento da razão BAX:BCL2. Houve um aumento da produção de AVOs nas linhagens celulares após o tratamento com a droga, o que sugere ativação da autofagia. Portanto, este estudo demonstra a capacidade antitumoral de NVP-BKM120 contra linhagens celulares de LLA-T e LB. Nossos resultados sugerem que a diminuição da proliferação celular, após o tratamento com a droga, seja devido à redução da Ciclina B1 e que o aumento da razão BAX:BCL2 seja um dos mecanismos envolvidos na indução da apoptose / Abstract: The lymphoid neoplasms are a heterogeneous group of diseases caused by genetic alterations that were originated from hematopoietic progenitor cells of lymphoid origin, leading to uncontrolled clonal proliferation of B or T cells, and to the development of lymphoid leukemias and lymphomas. These findings emphasize the involvement of different signaling pathways involved in both the development and the maintenance of hematological malignancies. Constitutive activation of the PI3K /AKT/mTOR signaling pathway is well described for acute lymphoblastic leukemia T cells (T-ALL), recently been identified in animal models, that the activity of PI3K cooperates with the development of Burkitt's lymphoma (LB).Thus, the role of the PI3K / AKT / mTOR pathway in cell growth and survival, two important features of leukemogenesis, morphed into a potential drug target. Following this perspective, the present study aimed to evaluate the therapeutic potential of NVP-BKM120, a pan-PI3K inhibitor class I in cell lines of T-ALL (Jurkat and MOLT-4) and LB (Daudi and NAMALWA). NVP-BKM120 was able to decrease cell viability and clonogenic capacity of these cells. A blocked phase was observed in G2/M phase of the cell cycle with subsequent reduction of Cyclin B1 and increased apoptosis by the intrinsic and extrinsic pathways in the lines Jurkat and MOLT-4 NAMALWA. It was also observed, decreased phosphorylation of AKT and of the downstream targets mTORC1, p70S6K and 4EBP1, and an increase of BAX:BCL2 ratio. There was an increase in AVOs production in the cell lines after treatment with the drug, suggesting activation of autophagy. Therefore, this study demonstrates the antitumor ability of NVP-BKM120 against cell lines of T-ALL and LB. Our results suggest that the decrease in cell proliferation after treatment with the drug, is due to the reduction of Cyclin B1 and the increase of the BAX:BCL2 ratio is one of the mechanisms that are involved in the induction of apoptosis / Mestrado / Fisiopatologia Médica / Mestre em Ciências

Abstract Neurofibromatosis type 1 syndrome (NF1) is caused by mutations of the NF1 gene. The NF1 protein (neurofibromin) contains a domain which is related to the GTPase-activating protein (GAP) and accelerates the switch of active Ras-GTP to inactive Ras-GDP. The NF1 protein has been referred to as a tumor suppressor, since the cells of malignant schwannomas of NF1 patients may display a loss of heterozygosity of the NF1 gene. Psoriasis is characterized by hyperproliferation of the epidermis and by down-regulated levels of NF1 mRNA and protein. Ca2+ is an universal signal transduction element modulating cell growth and differentiation. Many cell types coordinate their activities by transmitting waves of elevated intracellular calcium levels from cell to cell. The propagation of calcium waves had not been studied previously in human keratinocytes. Thus, the aim of the present study was to find out which pathways may play a role in Ca2+ signaling at different extracellular calcium concentrations in NF1 and and psoriatic keratinocytes versus normal control keratinocytes. The results demonstrated that NF1 and psoriatic keratinocytes have a tendency to form cultures characterized by altered Ca2+-mediated cell signaling compared to normal keratinocytes. Specifically, the main route of calcium-mediated signaling was gap-junctional in normal keratinocytes. In contrast, ATP-mediated calcium signaling predominated and capacitative calcium influx was defective in NF1 and psoriatic keratinocytes. The results of the present study suggest that mutations of the NF1 tumor suppressor gene or lowered levels of NF1 protein/mRNA may eventually lead to altered intercellular communication.

No description available.

Abstract Background – The heart cell is a prime example of a system, in which numerous interconnected regulatory mechanisms affect the dynamic balance of cellular function. The function of the system emerges from the interactions of its components rather than from their individual properties. Thus, it is a challenging task to understand the causal relations within such a system, based on the analysis of experimental results. Facing this complexity, the systems biological approach has gained interest during recent years, since with using it we can make an effort to observe, quantitatively and simultaneously, multiple components and their interdependencies in biological networks. Methods and aims – One of the most important tools in systems biology is mathematical modelling. In this thesis, novel model components have been developed and existing components integrated to describe mathematically the calcium dynamics in cardiac myocytes with improved physiological accuracy. Special attention was paid to both the activity-dependent and automatic regulation of the dynamics. This enabled the quantitative analysis of the regulation’s role in both physiological and pathophysiological conditions. Results – Validation of the novel model components that describe the calcium transport mechanisms indicates that the developed schemes are accurate and applicable also beyond the normal physiological state of the cardiac myocyte. Results also highlight the importance of autoregulation of calcium dynamics in the excitation-contraction coupling. Furthermore, the analysis indicates that the CaMK-dependent regulation of the calcium uptake to and release from the sarcoplasmic reticulum calcium stores could have substantial roles as downstream effectors in beta-adrenergic stimulation. Conclusions – Results emphasize mathematical modelling as a valuable complement to experiments in understanding causal relations within complex biological systems such as the cardiac myocytes. That is, rigorous data integration with mathematical models can provide significant insight to the quantitative role of both the individual model components and the interconnected regulatory loops. This is especially true for the analysis of genetically engineered animal models, in which the intended modification is always accompanied by compensatory changes that can mask to a varying degree the actual phenomenon of interest.

The Salvador/Warts/Hippo (Hippo) pathway defines a novel signalling cascade regulating cell contact inhibition, organ size control, cell growth, proliferation, apoptosis and cancer development in mammals. The Hippo pathway was initially utilised in D. melanogaster, where the Expanded protein acts in the Hippo signalling cascade to control organ size. Willin is the proposed human orthologue of Expanded and the aim of this thesis is to investigate whether willin can activate the mammalian Hippo signalling pathway. Ectopic willin expression causes an increase in phosphorylation of the core Hippo signalling pathway components MST1/2, LATS1 and YAP, an effect which can be antagonised by ezrin. In MCF10A cells, willin over-expression antagonises a YAP-induced epithelial-to-mesenchymal transition via the N- terminal FERM (Four-point-one Ezrin Radixin Moesin) domain of willin. Preliminary results show that willin is expressed within the sciatic nerve of rat and mice, and within the neuromast cells in the zebrafish; suggesting that willin and the Hippo pathway may play a vital role in the developmental regulation within the peripheral nervous system. To conclude, willin influences Hippo signalling activity by activating the core Hippo pathway kinase cassette in mammalian cells.

Self-renewal of mouse embryonic stem (mES) cells is dependent upon the presence of leukemia inhibitory factor (LIF). LIF induces tyrosine phosphorylation and nuclear translocation of STAT3 (signal transducer and activator of transcription 3) which is thought to promote self-renewal by inducing key target genes. The molecular chaperone heat shock protein 90 (Hsp90) is involved in signal transduction pathways and regulates STAT3 activity in different cell types. However, the role of Hsp90 in regulating STAT3 activity in mES cells has not previously been investigated. The aim of this study was to investigate if Hsp90 interacts with STAT3 in mES cells and to determine if this interaction is important for the maintenance of self-renewal. It was found that when mES cells were cultured for 24.0 hours in the absence of LIF, the expression levels of total STAT3, tyrosine-phosphorylated STAT3 (pYSTAT3), and the pluripotency marker, Nanog, were down regulated. However, the expression level of Hsp90 was found to be slightly up-regulated over the same period. Significantly, it was found that the amount of STAT3 in differentiating mES cells available for binding to Hsp90 was decreased upon down-regulation of STAT3 by LIF withdrawal. Therefore, STAT3-Hsp90 interactions in mES cells were dependent on the presence of LIF, which suggested that the reduction in STAT3-Hsp90 interaction may have resulted from the low levels of STAT3. Despite a dramatic reduction in the expression levels of pYSTAT3 upon 24.0 hours of culture of mES cells in the presence of the STAT3 tyrosine phosphorylation inhibitor, cucurbitanin I, there was no obvious reduction in the levels of total STAT3, Oct-3/4 or Nanog. These results suggested that the levels of unphosphorylated STAT3 rather than pYSTAT3, maybe more important in the maintenance of mES cells self-renewal.